Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

117
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
117
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

90
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
90
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

57
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
57
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

48
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of small-molecule HSF1 amplifiers by high content screening in protection of cells from stress induced injury.

Biochemical and biophysical research communications·2009
Same author

Nanowire transformation by size-dependent cation exchange reactions.

Nano letters·2009
Same author

Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial.

Journal of alternative and complementary medicine (New York, N.Y.)·2009
Same author

Identification of inhibitors of HSF1 functional activity by high-content target-based screening.

Journal of biomolecular screening·2009
Same author

Antitumor effects of targeting hTERT lentivirus-mediated RNA interference against KB cell lines.

Oncology research·2009
Same author

Characteristics of emissive spectrum and the removal of nitric oxide in N2/02/NO plasma with argon additive.

Journal of environmental sciences (China)·2009

Related Experiment Video

Updated: Jul 5, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Individualized Texture Similarity Network in Schizophrenia.

Hao Ding1, Yu Zhang2, Yingying Xie2

  • 1Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin, China; School of Medical Imaging, Tianjin Medical University, Tianjin, China.

Biological Psychiatry
|January 13, 2024
PubMed
Summary

Researchers developed a new method called a texture similarity network (TSN) to map how brain regions share structural patterns. By analyzing brain scans from hundreds of people, they found that patients with schizophrenia exhibit unique, complex patterns of brain connectivity and structural variability that differ significantly from healthy individuals and those with depression.

Keywords:
Gray-level co-occurrence matrixIntersubject variabilitySchizophreniaStructural covarianceSubject-level similarity networkTexture analysisstructural covariancebrain connectivitygray-level co-occurrence matrixpsychiatric neuroimaging

Frequently Asked Questions

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.4K
Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
13:08

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

Published on: December 2, 2015

8.9K

Related Experiment Videos

Last Updated: Jul 5, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.4K
Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
13:08

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia

Published on: December 2, 2015

8.9K

Area of Science:

  • Neuroimaging and texture similarity network analysis in psychiatry
  • Computational neuroscience and structural brain connectivity research

Background:

Structural covariance network disruption remains a primary marker for understanding psychiatric conditions. Prior research has shown that traditional connectivity metrics often fail to capture the full spectrum of individual brain variations. No prior work had resolved how specific gray-level feature maps might better characterize these subtle structural differences. That uncertainty drove the development of more granular, individualized mapping techniques. Existing models frequently overlook the complex intersubject heterogeneity present in clinical populations. This gap motivated the exploration of texture-based metrics to improve diagnostic sensitivity. Scientists have long sought reliable indicators to distinguish schizophrenia from other mood disorders. The current study addresses these limitations by introducing a novel framework for assessing brain architecture.

Purpose Of The Study:

The study aims to introduce a novel individualized structural covariance network measure to characterize brain architecture. Researchers sought to determine if this texture-based metric could reliably reveal unique intersubject heterogeneity. They hypothesized that the approach would uncover complex dysconnectivity patterns specific to schizophrenia. The team addressed the challenge of identifying consistent pathophysiological indicators in psychiatric populations. This motivation stemmed from the limitations of existing structural covariance models in capturing individual differences. The authors intended to validate the reproducibility of their method across multiple healthy and clinical cohorts. They also aimed to compare these findings against depression to establish diagnostic specificity. This work provides a framework for understanding how brain organization shifts in patients with schizophrenia.

Main Methods:

The investigation employed a novel individualized structural covariance network approach to analyze brain architecture. Researchers constructed these networks by calculating the covariance of 180 three-dimensional voxelwise gray-level co-occurrence matrix feature maps. This process occurred for every participant to ensure individualized mapping. The team validated the framework using two longitudinal test-retest cohorts of healthy individuals. They subsequently applied the model to ten distinct schizophrenia case-control datasets. This secondary phase included 609 patients and 579 healthy controls to ensure robust statistical power. The authors also incorporated a first-episode depression dataset for comparative analysis. This design allowed for the assessment of diagnostic specificity across different psychiatric conditions.

Main Results:

The analysis demonstrated that the texture similarity network reliably reveals higher intersubject variability in both chronic and first-episode schizophrenia. This pattern did not appear in the depression cohort, highlighting diagnostic specificity. The researchers detected coexistent increased and decreased connection strengths in widespread brain regions for patients with schizophrenia. They also identified increased global small-worldness within these patient groups. The data showed structural hyposynchronization in central networks alongside hypersynchronization in peripheral networks. These findings were absent in the depression patient group. The study reported that these aberrant patterns showed weak or missing correlations with functional connectivity metrics. Finally, the results indicated that regional volume changes did not account for the observed structural covariance differences.

Conclusions:

The authors propose that the texture similarity network serves as a reliable tool for identifying unique structural heterogeneity. Their findings suggest that schizophrenia involves complex dysconnectivity patterns not present in depression. The researchers highlight that these structural changes include both increased and decreased connection strengths across widespread regions. They observe that patients with schizophrenia exhibit higher global small-worldness compared to control groups. The study indicates that structural hyposynchronization occurs within central networks while hypersynchronization appears in peripheral areas. The authors report that these specific patterns do not correlate strongly with traditional functional connectivity or regional volume metrics. These results imply that texture-based measures provide distinct information about brain architecture. The team concludes that this approach effectively captures the unique pathophysiological signatures of schizophrenia.

The researchers propose that the texture similarity network identifies unique structural heterogeneity and complex dysconnectivity. This method reveals coexistent increased and decreased connection strengths, alongside global small-worldness, which distinguishes patients with schizophrenia from those with depression.

The framework utilizes 180 three-dimensional voxelwise gray-level co-occurrence matrix feature maps. These maps allow for the calculation of covariance between distinct brain areas for every individual participant.

The authors emphasize that this method is necessary to capture intersubject variability that traditional functional connectivity or regional volume metrics often miss. This distinction ensures the network provides unique insights into brain architecture.

The researchers applied this approach to 10 schizophrenia case-control datasets, totaling 609 patients and 579 controls. They also compared these results against a dataset of 69 patients with depression and 69 matched controls.

The team measured intersubject versus intrasubject variability to confirm reproducibility. They found that intersubject variability was consistently higher, confirming the tool reliably detects individual differences across longitudinal test-retest cohorts.

The researchers propose that their findings support the use of this network to uncover specific pathophysiological indicators. They claim this approach provides a more granular view of brain organization than standard structural covariance measures.